TGFB1 and cancer: We suggest that WM inhibits TGF-β induced EMT in colon cancer by blocking TGF-β induced expression of PD-L1 in cancer cells (Figure 4C) which may likely prevent tumor evasion from the immune system, possibly implicating its utility as an anticancer agent.